With the Pfizer vaccine having been approved, the Moderna vaccine all but certain to be approved, and the prospects of other key players in the COVID-19 vaccine race factored into their respective share prices, what’s the best way for investors to engage with biopharma and biotech companies going forward? CLICK HERE.